Decisiondx®-melanoma outperforms memorial sloan kettering cancer center (mskcc) nomogram in predicting sentinel lymph node positivity in patients with cutaneous melanoma

Friendswood, texas--(business wire)---- $cstl #cstl--castle announced a new study demonstrating decisiondx®-melanoma outperforms the mskcc nomogram in identifying patients at low risk of sln positivity.

CSTL Ratings Summary

CSTL Quant Ranking